- Category
- Medium (2024-25)
- Udyam number
- UDYAM-DL-08-0009558

Anm Pharma Private Limited
About Anm Pharma Private Limited
Data last updated:
Anm Pharma Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 24 December 2013 and has been in existence for over 13 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24233DL2013PTC262682. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹3 Cr and a paid-up capital of ₹2.31 Cr. It is led by directors including Anshul Sikri and Nidhi Arora.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 208 Okhla Industrial Estate Phase – III, New Delhi, Delhi, India – 110020.
As per the financials filed for FY 2025, the company reported a revenue of ₹190.81 Cr, a growth of 3% compared to the previous year. For the same year it recorded a net profit of ₹54.72 Lakh (net margin 0.3%) and EBITDA of ₹1.14 Cr (EBITDA margin 0.6%). Revenue has grown at a compounded annual rate (CAGR) of 1% over three years and 1% over five years.
The company has about 4 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Nishchem. As per MCA filings, the company has open charges of ₹65 Cr and satisfied charges of ₹50 Cr on record. Court records list 15 cases involving the company, including 9 filed by the company and 6 filed against it; 7 cases are pending. The company has 3 deals on record (1 rights issue, 1 funding round, 1 secondary share transfer), with disclosed funding of ₹6.6 Lakh; the latest was in October 2014. Its 5 peer companies in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading) are compared by revenue, 3 larger and 2 smaller; the largest is SMPL Life Sciences Private Limited with revenue of ₹194.66 Cr.
Anm Pharma Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-08-0009558). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Recognitions & Rankings of Anm Pharma
Contact details
Anm Pharma Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address208 Okhla Industrial Estate Phase – III, New Delhi, Delhi, India – 110020
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Anm Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Anm Pharma operates one associated brand: Nishchem. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufactures and distributes pharmaceutical APIs and formulations globally with import and export services. | nishchem.com |
Business activity
The main business activity of Anm Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Anm Pharma Private Limited, buy the company report.
Financials of Anm Pharma Private Limited
FY 2025 filings availableAnm Pharma Private Limited reported revenue of ₹190.81 Cr (up 3% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 1% over five years, including 3% growth in the latest year. EBITDA fell 64% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.14 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹54.72 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.6% | ||||
| Net Profit Margin | 0.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Anm Pharma Private Limited, buy the company report.
Board of directors of Anm Pharma Private Limited
Anm Pharma has 3 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anshul Sikri Also directs: Berg Healthcare LLP, Vaxer Pharma Limited | Director | 03 Feb 2014 | 12 Years 8 Months | Current |
| Nidhi Arora Also directs: Shevini Ventures LLP, Virmish Enterprises Private Limited, Arora Family Private Limited and 1 more | Director | 03 Feb 2014 | 12 Years 8 Months | Current |
| Bharat Balubhai Shah | Director | 03 Feb 2014 | 12 Years 8 Months | Current |
Peer comparison
Anm Pharma Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| SMPL Life Sciences Private Limited | ₹194.66 Cr (FY 2025) | 6.0% | New Delhi, Delhi, India | |||
| Sood Medicine Traders Private Limited | ₹194.03 Cr (FY 2025) | 7.0% | Punjab, India | |||
| Livanova India Private Limited | ₹192.91 Cr (FY 2025) | 41.0% | Gurgaon, Haryana, India | |||
| Anm Pharma Private Limitedthis company | ₹190.81 Cr (FY 2025) | ₹54.72 Lakh | 0.3% | 3.0% | 4 | New Delhi, Delhi, India |
| Kaushal Pharmaceuticals Private Limited | ₹186.1 Cr (FY 2025) | 13.0% | Kolkata, West Bengal, India | |||
| Dadha Pharma Distribution Limited | ₹182.54 Cr (FY 2025) | -7.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Anm Pharma Private Limited, buy the company report.
Auditor
Anm Pharma Private Limited is audited by BHAGI BHARDWAJ GAUR & CO. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| BHAGI BHARDWAJ GAUR & CO. | FY 2023 | 007895N |
Shareholding
The shareholding of Anm Pharma Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Anm Pharma Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 05 Aug 2020 | 100404880 | Hdfc Bank Limited | ₹15 Cr | Open | |
| 13 Feb 2014 | 10494439 | Yes Bank Limited | ₹50 Cr | Open | |
| 02 Feb 2016 | 100019791 | Others | ₹50 Cr | Satisfied |
To see the full charge records of Anm Pharma Private Limited, buy the company report.
Total charge records: 3 View all charges
Deals & funding
Anm Pharma Private Limited has 3 deals on record (1 rights issue, 1 funding round, 1 secondary share transfer), with disclosed funding of ₹6.6 Lakh; the latest was in October 2014.
Deals on record (3 of 3)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Oct 2014 | Secondary share transfer | Undisclosed | Buyer: Mankind Pharma Limited Seller: 2 individuals |
| Apr 2014 | Rights issue | ₹2.24 Cr | Investors: Mankind Pharma Limited , Abs Mercantiles Private Limited , Nishchem International Private Limited |
| Mar 2014 | Funding round | ₹6.6 Lakh | Investors: Abs Mercantiles Private Limited , Nishchem International Private Limited |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Anm Pharma Private Limited has 15 court cases on record: 9 filed by Anm Pharma, 6 filed against it. 7 cases are pending and 8 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 7 | 5 | 2 |
| NCLAT | 4 | 0 | 4 |
| High courts | 3 | 1 | 1 |
| NCLT | 1 | 0 | 0 |
Cases on record (5 of 15)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Bombay High Court | Writ petition | Filed against the company by Centurion Laboratories Pvt. Ltd. and Ors | Pending |
| NCLAT, NCLAT New Delhi | Insolvency matter | Filed by the company against Centurion Laboratories Private Limited | Pending |
| NCLAT, NCLAT New Delhi | Interim or miscellaneous application | Filed by the company against Centurion Laboratories Private Limited | Pending |
| District court, Mumbai CMM Courts, Maharashtra | Court case (SUMMARY CASE) | Filed by the company against Centurion Laboratories Private Limited. and 3 others | Pending |
| NCLT, Ahmedabad | Insolvency matter | Filed by the company against Centurion Laboratories Private Limited | Disposed |
To see the full case history of Anm Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
Anm Pharma Private Limited was last rated by Care on 07 Jan 2022.
| Rating agency | Rated on | Rating |
|---|---|---|
| Care | 07 Jan 2022 |
To see the full credit ratings and regulatory alerts of Anm Pharma Private Limited, buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Anm Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Anm Pharma Private Limited has a workforce of 4 employees on its EPFO records as of Mar 28, 2024, across 1 active EPFO establishment.
GST
Anm Pharma has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Anm Pharma Private Limited, buy the company report.
Recent activity
Anm Pharma Private Limited has 8 board changes on record since 2014: 3 appointments and 5 cessations. The latest: Bharat Balubhai Shah ceased to be Director on 01 Apr 2017.
6 earlier events are in the company report.
Frequently asked questions
Anm Pharma is an active private limited company based in New Delhi, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 24 December 2013 (13+ years old) and is registered under CIN U24233DL2013PTC262682.
Anm Pharma has 3 current directors:
- Anshul Sikri - Director
- Nidhi Arora - Director
- Bharat Balubhai Shah - Director
The latest financial statements of Anm Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
No. Anm Pharma has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Anm Pharma is U24233DL2013PTC262682. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Anm Pharma has 15 court cases on record: 9 filed by the company and 6 filed against it. 7 are pending. Most are in the district courts.
Anm Pharma was incorporated on 24 December 2013, making it 13+ years old. It is registered with the Registrar of Companies, Delhi.
Anm Pharma has 3 deals on record (1 rights issue, 1 funding round, 1 secondary share transfer), with disclosed funding of ₹6.6 Lakh; the latest was in October 2014.
The peers of Anm Pharma by revenue are SMPL Life Sciences Private Limited, Sood Medicine Traders Private Limited, Livanova India Private Limited, Kaushal Pharmaceuticals Private Limited, Dadha Pharma Distribution Limited, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Bharat Balubhai Shah ceased to be Director on 01 Apr 2017. Anshul Sikri ceased to be Additional Director on 15 Oct 2014. Nidhi Arora ceased to be Additional Director on 15 Oct 2014. Anm Pharma has 8 board changes on record in total.
Yes, Anm Pharma is registered as a medium enterprise under Udyam registration (number: UDYAM-DL-08-0009558).